AstraZeneca
cash flow net debt and financial guidance continued improvement net debt bridge updated guidance total revenue mid single digit increase previously low to mid single digit increase total revenue excluding covid medicines low teens increase previously low double digit increase core low double digit to low teens increase previously high single digit to low double digit increase | AstraZeneca
Company
Deck Type
Deck date
November 2023
Slide
11 of 45
Similar slides by AstraZeneca
Results
February 2024
Results
July 2023
Results
April 2023
Results
February 2023
Related slides by other companies
Results
February 2023
Results
July 2023
Results
October 2022
Results
April 2023
Other recent decks by AstraZeneca
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2024 Slidebook.io